Bots, editor, reviewer, Administrators
13,941
edits
Feed:All articles/Pretty: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 148: | Line 148: | ||
}, | }, | ||
{ | { | ||
"timestamp" : "2014-05- | "timestamp" : "2014-05-27T04:26:16Z", | ||
"briefDesignDescription" : "Rate vs. rhythm control in AF", | "briefDesignDescription" : "Rate vs. rhythm control in AF", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa021328", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa021328", | ||
| Line 2,650: | Line 2,650: | ||
}, | }, | ||
{ | { | ||
"timestamp" : " | "timestamp" : "2014-05-27T04:59:32Z", | ||
"briefDesignDescription" : "Dexmedetomidine vs. midazolam for sedation", | "briefDesignDescription" : "Dexmedetomidine vs. midazolam for sedation", | ||
"fulltexturl" : "http://jama.ama-assn.org | "fulltexturl" : "http://jama.ama-assn.org/content/301/5/489.long", | ||
"pageid" : 353, | "pageid" : 353, | ||
"pdfurl" : "http://jama.ama-assn.org | "pdfurl" : "http://jama.ama-assn.org/content/301/5/489.full.pdf", | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Riker RR, <i>et al</i>. \"Dexmedetomidine vs. Midazolam for Sedation of Critically Ill Patients\". <i>Journal of American Medical Association</i>. 2009. 301(5):489-499.", | "citation" : "Riker RR, <i>et al</i>. \"Dexmedetomidine vs. Midazolam for Sedation of Critically Ill Patients\". <i>Journal of American Medical Association</i>. 2009. 301(5):489-499.", | ||
| Line 3,080: | Line 3,080: | ||
"title" : "Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina -- Results of a Veterans Administration Cooperative Study", | "title" : "Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina -- Results of a Veterans Administration Cooperative Study", | ||
"pmid" : "6135989" | "pmid" : "6135989" | ||
}, | |||
{ | |||
"timestamp" : "2014-05-27T06:33:03Z", | |||
"briefDesignDescription" : "ARB+ACE-inhibitor for DM nephropathy", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1303154", | |||
"pageid" : 1798, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1303154", | |||
"trainingLevel" : "Resident\n}}", | |||
"citation" : "Fried LF, <i>et al</i>. \"Combined angiotensin inhibition for the treatment of diabetic nephropathy\". <i>The New England Journal of Medicine</i>. 2013. 369(20):1892-1903.", | |||
"subspecialties" : "Nephrology;Endocrinology", | |||
"expansion" : "Veterans Affairs Nephropathy in Diabetes", | |||
"briefResultsDescription" : "ARB+ACE-inhibitor no more effective than monotherapy, increases complications", | |||
"published" : "2013-11-14", | |||
"pageName" : "VA-NEPHRON D", | |||
"diseases" : "Diabetes Mellitus;Diabetic Nephropathy", | |||
"abbreviation" : "VA NEPHRON-D", | |||
"title" : "Combined angiotensin inhibition for the treatment of diabetic nephropathy", | |||
"pmid" : "24206457" | |||
}, | }, | ||
{ | { | ||